Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal
Neuroscience Applied
Date
2021-12-31
Source
OpenAlex
DOI
10.1016/j.nsa.2022.100213
PubMed
Unavailable

Authors

G. GoodwinScott T. AaronsonBoadie W. DunlopD. FeifelDavid J. HellersteinL. MarwoodS. MistryMetten SomersS.C. StansfieldJ. TsaiS. WilliamsAllan H. YoungSidney ZisookE. Malievskaia
Watch author

Topics and keywords

psilocybin DepressionClinical TrialRandomized Controlled TrialTreatment-Resistant Depression Randomized Controlled Trial PsilocybinDepression (economics)PsychotherapistPsychologyTreatment-resistant depressionRandomized controlled trialPsychiatryMedicineClinical psychologyInternal medicineHallucinogenMajor depressive disorderCognitionEconomicsMacroeconomicsPsychedelics and Drug StudiesDigital Mental Health InterventionsMental Health Research Topics

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial2021-12-31

Related papers

Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidenceZenodo (CERN European Organization for Nuclear Research) · 2026-01-25194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15